Exhibit 99.2
Unaudited Pro Forma Financial Statements
The following Unaudited Pro Forma Financial Statements give effect to the sale of the Mega-T brand of weight loss and dietary supplements on August 26, 2014, and the discontinuation of the Gel Perfect brand of color nail polish. These Pro Forma Financial Statements are based upon our audited financial statements for the fiscal years ended November 30, 2011, 2012 and 2013 and the unaudited interim statements for the quarter and year to date ended on May 31, 2013 and 2014, and the related notes and certain estimates, adjustments and assumptions that our management believes to be reasonable. The Unaudited Pro Forma operations for the fiscal years ended November 31, 2011, 2012 and 2013 and the year to date ended May 31, 2013 and 2014 are presented giving effect to the removal of the revenue and direct expenses of Mega-T as if the sale occured upon the first day of the period presented. Additional the Unaudited Pro Forma Statement of Operations for the fiscal years ended November 30, 2011, 2012, and 2013 reflect the removal of Gel Perfect revenue and direct expenses, which was discontinued by the Company on May 31, 2014. The Unaudited Pro Forma Balance Sheet as of May 31, 2014 reflects the sale of Mega-T as if it occured on May 31, 2014.
Gel Perfect adjustments are not reflected separately in the pro forma financial statements for the six months ended May 31, 2014 and 2013, as the effect of the discontinuation of the brand was already reported on the Form 10-Q for the period ended May 31, 2014.
Under the Asset Purchase Agreement, the Company, on August 26, 2014 sold to LLC all of the inventory, including packaging materials, finished goods, raw materials and work-in-process, as well as the trademarks, domain names, goodwill and going concern value of the Mega-T brand of weight loss and dietary supplement products. Excluded from the sale were accounts receivable related to the Mega-T brand, which are retained by the Company.
In consideration of the sale, LLC assumed liabilities for all deductions with respect to returns of Mega-T brand inventory that were held by the retailers as of or prior to the date of closing, other than those that were already deducted, all deductions for Mega-T co-operative advertising events that occurred prior to the closing date and were not already deducted by the retailers and all deductions for contract markdown commitments related to the Mega-T brand that were made prior to the closing date and were not already deducted by the retailer. The amount of liabilities assumed by LLC is subject to a cap of $2,250,000. In addition, LLC assumed liabilities for all outstanding purchase orders for Mega-T brand inventory to the extent that LLC receives that inventory from the vendor. LLC also assumed all of the liabilities and obligations with respect to the MEGA-T business that arise after the closing relating to the LLC’s operation of the MEGA-T business. The Company is responsible for paying vendors for any Mega-T inventory received by the Company prior to the closing date.
Pro forma information is intended to provide investors with information about the continuing impact of a transaction by showing how a specific transaction(s) might have affected historical financial statements, illustrating the scope of the change in the historical financial position and results of operation. The adjustments made to historical financial information give effect to the sale of the Mega-T brand and the discontinuation of the Gel Perfect brand. The Unaudited Pro Forma Financial Statements are prepared in accordance with Rule 8-05 of Regulation S-X.
The Unaudited Pro Forma Financial Statements set forth below are not fact and there can be no assurance that our actual results will not differ significantly from those set forth below or that the impact of the Mega-T sale and discontinuation of the Gel Perfect brand will not differ significantly from those presented below. Accordingly, the Pro Forma Financial Statements are presented for illustrative purposes only and do not purport to represent, and are not necessarily indicative of, what our actual financial position and results of operations would have been had the Mega-T sale and discontinuation of Gel Perfect had occurred on the dates indicated, nor are they indicative of our future financial position or results of operation. Readers of this 8-K are cautioned not to place undue reliance on such information and no one makes any representation regarding the information set forth below or our ultimate performance compared to it.
EXHIBIT 99.2
|
| | | | | | | | |
CCA INDUSTRIES, INC. AND SUBSIDIARIES |
UNAUDITED PRO-FORMA CONSOLIDATED BALANCE SHEETS AS OF MAY 31, 2014 |
| | | | | | | | |
A S S E T S |
| | | | | | | | |
| | | | | | | | |
| | | | May 2014 | Mega-T Proforma Adjustments | | Proforma | |
| | | | (Unaudited) | (1) | | | |
Current assets | | | | | | |
| Cash & cash equivalents | | $ 1,536,996 | - | | 1,536,996 | |
| Short term investments & marketable | | | | | | |
| | securities | | 408,455 | - | | 408,455 | |
| Accounts Receivable, net of allowances of | | | | | | |
| | $2,104,551 and $1,081,277 respectively | | 5,161,649 | 713,951 | (2) | 5,875,600 | |
| Inventories, net of reserve for obsolescence of | | 7,324,295 | (1,002,909) | | 6,321,386 | |
| | $2,836,831 and $3,030,306, respectively | | | | | | |
| Prepaid expenses and sundry receiveables | | 459,921 | - | | 459,921 | |
| Prepaid and refundable income taxes | | 675,453 | - | | 675,453 | |
| Deferred income taxes | | 4,831,903 | (390,457) | | 4,441,446 | |
| | | | | | | | |
| | Total Current Assets | | 20,398,672 | (679,415) | | 19,719,257 | |
| | | | | | | | |
| Property and Equipment, net of accumulated | | | | | | |
| depreciation and amortization | | 1,352,462 | - | | 1,352,462 | |
| Intangible Assets, net of accumulated | | | | | | |
| amortization | | 751,973 | - | | 751,973 | |
| Deferred income taxes | | 2,919,011 | - | | 2,919,011 | |
| Other | | - | - | | - | |
| | | | 5,023,446 | - | | 5,023,446 | |
| | | | | | | | |
| | Total Assets | | $ 25,422,118 | $ (679,415) | | 24,742,703 | |
|
| | | | | | | |
CCA INDUSTRIES, INC. AND SUBSIDIARIES |
UNAUDITED PRO-FORMA CONSOLIDATED BALANCE SHEETS AS OF MAY 31, 2014 |
| | | | | | | |
LIABILITIES AND SHAREHOLDERS' EQUITY |
| | | | | | | |
| | | | | | | |
| | | | May 2014 | Mega-T Proforma Adjustments | Proforma | |
| | | | (Unaudited) | (1) | | |
Current Liabilities | | | | | |
| Accounts payable & accrued liabilities | | $ 13,757,188 | (1,347,108) | 12,410,080 | |
| Capital Lease Obligation - Current Portion | | 7,374 | — | 7,374 | |
| | Total current liabilities | | 13,764,562 | (1,347,108) | 12,417,454 | |
| | | | | | |
Capitalized Lease Obligations | | 26,242 | — | 26,242 | |
| Total Liabilities | | 13,790,804 | (1,347,108) | 12,443,696 | |
| | | | | | | |
Shareholders' Equity | | | | | |
| Preferred stock, $1.00 par, authorized 20,000,000 | | | | | |
| none issued | | — | — | — | |
| Common stock, $.01 par, authorized 15,000,000 | | | | | |
| 6,038,982 shares issued | | 60,390 | — | 60,390 | |
| Class A common stock, $.01, authorized 5,000,000 | | | | |
| 967,702 shares issued and outstanding | | 9,677 | — | 9,677 | |
| Additional paid-in capital | | 2,339,849 | — | 2,339,849 | |
| Retained earnings | | 9,104,602 | 667,693 | 9,772,295 | |
| Unrealized Gains (losses) on marketable securities | 116,796 | — | 116,796 | |
| Total Shareholders' Equity | | 11,631,314 | 667,693 | 12,299,007 | |
| | | | | | |
| | Total Liabilities and Shareholders' Equity | | $ 25,422,118 | $ (679,415) | 24,742,703 | |
(1) represents value of sales return liabilities assumed, inventory transferred to the acquirer, and corresponding gain of $667,693, net of tax of $390,457. |
(2) Reflects reversal of accounts receivable reserves related to the Mega-T brand. |
|
| | | | | |
CCA INDUSTRIES, INC. AND SUBSIDARIES |
UNAUDITED PRO-FORMA STATEMENT OF OPERATIONS |
FOR THE SIX MONTHS ENDED MAY 31, 2014 |
| | | | | |
| | | | | |
| | | May 2014 | Mega-T Proforma Adjustments | ProForma |
| | | | (3) | |
Revenues | | | | | |
Sales of Health and Beauty | $ 16,023,232 | $ (819,806) | $ 16,843,038 |
| aid products-Net | | | | |
| Other Income | | $ 244,543 | — | $ 244,543 |
| | | | | |
| | | $ 16,267,775 | $ (819,806) | $ 17,087,581 |
| | | | | |
| | | | | |
Costs and Expenses | | | | |
| Cost of sales | | $ 9,094,857 | $ (1,744,988) | $ 7,349,870 |
| Selling, general and | | $ 7,517,964 | $ (314,701) | $ 7,203,263 |
| administrative | | | | |
| expenses | | | | |
| Advertising, Cooperative | | | | |
| and promotions | | $ 2,989,338 | $ (337,910) | $ 2,651,428 |
| Research and development | | $ 264,214 | — | $ 264,214 |
| Provision for doubtful | | | — | 0 |
| accounts | | $ (22,340) | — | $ (22,340) |
| Interest expense | | $ 1,526 | — | $ 1,526 |
| | | | | |
| Total Costs and Expenses | | $ 19,845,560 | $ (2,397,599) | $ 17,447,961 |
| Restructuring Costs | | $ 563,572 | — | $ 563,572 |
| Total Costs and Expenses | | $ 20,409,132 | $ (2,397,599) | $ 18,011,533 |
| | | | | |
| | | | | |
| (Loss) Income before (Benefit from) Provision for Income Tax | | $ (4,141,357) | $ (3,217,405) | $ (923,952) |
| | | | | |
| | | | | |
| (Benefit from) Provision for Income Tax | | $ (1,520,663) | $ (1,181,397) | $ (339,266) |
| | | | | |
| (Loss) from Continuing Operations | | $ (2,620,694) | $ (2,036,008) | $ (584,686) |
|
|
| | | | | |
| (Loss) per Share: | | | | |
| Basic | | | | |
| Continuing Operations | | $ (0.37) | $ (0.29) | $ (0.08) |
| | | | | |
| Diluted | | | | |
| Continuing Operations | | $ (0.37) | $ (0.29) | $ (0.08) |
| | | | | |
Number of Common Shares: | | | | |
Weighted average outstanding - Basic | | 7,006,684 | 7,006,684 | 7,006,684 |
Weighted average and potential dilutive outstanding | 7,006,684 | 7,006,684 | 7,006,684 |
(3) Represents unaudited revenue and direct expenses for Mega-T for the period ended May 31, 2014 |
|
| | | | | |
CCA INDUSTRIES, INC. AND SUBSIDARIES |
UNAUDITED PRO-FORMA STATEMENT OF OPERATIONS |
FOR THE SIX MONTHS ENDED MAY 31, 2013 |
| | | | | |
| | | | | |
| | | May 2013 | Mega-T Proforma Adjustments | ProForma |
| | | | (4) | |
Revenues | | | | | |
| Sales of Health and Beauty | | $ 19,907,242 | $ 3,887,078 | $ 16,020,164 |
| aid products-Net | | | | |
| Other Income | | $ 58,430 | — | $ 58,430 |
| | | | | |
| | | $ 19,965,672 | $ 3,887,078 | $ 16,078,594 |
| | | | | |
| | | | | |
Costs and Expenses | | | | |
| Cost of sales | | $ 9,029,657 | $ (1,431,749) | $ 7,597,908 |
| Selling, general and | | $ 10,058,846 | $ (388,123) | $ 9,670,723 |
| administrative | | | | |
| expenses | | | | |
| Advertising, Cooperative | | | | |
| and promotions | | $ 1,991,974 | $ (742,962) | $ 1,249,012 |
| Research and development | | $ 346,613 | — | $ 346,613 |
| Provision for doubtful | | | | |
| accounts | | $ (26,680) | — | $ (26,680) |
| Interest expense | | $ 462 | — | $ 462 |
| | | | | |
| Total Costs and Expenses | | $ 21,400,872 | $ (2,562,835) | $ 18,838,037 |
| Restructuring Costs | | | | 0 |
| Total Costs and Expenses | | $ 21,400,872 | $ (2,562,835) | $ 18,838,037 |
| | | | | |
| | | | | |
| (Loss) Income before (Benefit from) Provision for Income Tax | | $ (1,435,200) | $ 1,324,243 | $ (2,759,443) |
| | | | | |
| | | | | |
| (Benefit from) Provision for Income Tax | | $ (536,444) | $ 494,971 | $ (1,031,415) |
| | | | | |
| (Loss) from Continuing Operations | | $ (898,756) | $ 829,272 | $ (1,728,028) |
|
| | | | | | | | | | | |
| (Loss) Income per Share: | | | | |
| Basic | | | | |
| Continuing Operations | | $ | (0.13 | ) | $ | 0.12 |
| $ | (0.24 | ) |
| | | | | |
| Diluted | | | | |
| Continuing Operations | | $ | (0.13 | ) | $ | 0.12 |
| $ | (0.24 | ) |
| | | | | |
Number of Common Shares: | | | | |
Weighted average outstanding - Basic | | 7,054,442 | 7,054,442 | 7,054,442 |
Weighted average and potential dilutive outstanding | 7,054,442 | 7,054,442 | 7,054,442 |
(4) Represents unaudited revenue and direct expenses for Mega-T for the period ended May 31, 2013 |
|
| | | | | | | | | | | | | | | |
CCA INDUSTRIES, INC. AND SUBSIDIARIES |
UNAUDITED PRO-FORMA STATEMENT OF OPERATIONS |
FOR THE YEAR ENDED NOVEMBER 30, 2013 |
| | | | | | | |
| | | | | | | |
| | | | November 30, 2013 | GP Proforma Adjustment | Mega-T Proforma Adjustments | ProForma |
| | | | | (5) | (6) | |
Revenues | | | | | | |
| Sales of Health and Beauty | | | $ | 38,789,593 |
| $ | 3,415,685 |
| $ | 6,610,539 |
| $ | 28,763,368 |
|
| aid products-Net | | | | | | |
| Other Income | | | $ | 63,794 |
| — |
| — |
| $ | 63,794 |
|
| | | | | | | |
| | | | $ | 38,853,387 |
| $ | 3,415,685 |
| $ | 6,610,539 |
| $ | 28,827,162 |
|
| | | | | | | |
Costs and Expenses | | | | | | |
| Cost of sales | | | $ | 22,277,158 |
| $ | (3,913,014 | ) | $ | (3,246,912 | ) | $ | 15,117,232 |
|
| Selling, general and administrative | | | $ | 19,601,411 |
| $ | (573,684 | ) | $ | (682,443 | ) | $ | 18,345,284 |
|
| expenses | | | | | | |
| Advertising, Cooperative | | | | | | |
| and promotions | | | $ | 5,948,653 |
| (2,197,873 | ) | (829,581 | ) | $ | 2,921,199 |
|
| Research and development | | | $ | 741,694 |
| — |
| — |
| $ | 741,694 |
|
| Provision for doubtful | | | | | | |
| accounts | | | $ | 55,204 |
| — |
| — |
| $ | 55,204 |
|
| Interest expense | | | $ | 2,249 |
| — |
| — |
| $ | 2,249 |
|
| Total Costs and Expenses | | | $ | 48,626,369 |
| $ | (6,684,571 | ) | $ | (4,758,936 | ) | $ | 37,182,862 |
|
| | | | | | | |
| (Loss) Income before (Benefit | | | | | | |
| from) Provision for Income Taxes | | $ | (9,772,982 | ) | $ | (3,268,886 | ) | $ | 1,851,603 |
| $ | (8,355,699 | ) |
| | | | | | | |
| (Benefit from) Provision for | | | | | | |
| Income Taxes | | | $ | (3,579,734 | ) | $ | (1,197,356 | ) | $ | 678,221 |
| $ | (3,060,599 | ) |
| | | | | | | |
| Net (Loss) Income | | | $ | (6,193,248 | ) | $ | (2,071,530 | ) | $ | 1,173,382 |
| $ | (5,295,100 | ) |
| | | | | | | |
| Earnings per Share: | | | | | | |
| Basic | | | $ | (0.88 | ) | $ | (0.29 | ) | $ | 0.17 |
| $ | (0.75 | ) |
| Diluted | | | $ | (0.88 | ) | $ | (0.29 | ) | $ | 0.17 |
| $ | (0.75 | ) |
| | | | | | | |
Number of Common Shares: | | | | | | |
Weighted average outstanding - Basic | | 7,037,694 | 7,037,694 | 7,037,694 | 7,037,694 |
Weighted average and potential dilutive outstanding | | 7,037,694 | 7,037,694 | 7,037,694 | 7,037,694 |
(5) Represents unaudited revenue and direct expenses for Gel Perfect for the year ended November 30, 2013 |
(6) Represents unaudited revenue and direct expenses for Mega-T for the year ended November 30, 2013 |
|
| | | | | | | | | | | | | | | |
CCA INDUSTRIES, INC. AND SUBSIDARIES |
UNAUDITED PRO-FORMA STATEMENT OF OPERATIONS |
FOR THE YEAR ENDED NOVEMBER 30, 2012 |
| | | | | | | |
| | | | | | | |
| | | | November 30, 2012 | GP Proforma Adjustment | Mega-T Proforma Adjustments | ProForma |
| | | | | (7) | (8) | |
Revenues | | | | | | |
| Sales of Health and Beauty aid products - Net | | | $ 53,169,022 | $ | 10,653,544 |
| $ | 10,270,646 |
| $ | 32,244,832 |
|
| | | | | | | |
| Other Income | | | $ 606,653 | — |
| — |
| $ | 606,653 |
|
| | | | | | | |
| | | | $ 53,775,675 | $ | 10,653,544 |
| $ | 10,270,646 |
| $ | 32,851,485 |
|
| | | | | | | |
Costs and Expenses | | | | | | |
| Cost of sales | | | $ | 23,219,051 |
| $ | (4,457,819 | ) | $ | (3,551,377 | ) | $ | 15,209,855 |
|
| Selling, general and | | | $ | 21,727,273 |
| $ | (1,303,884 | ) | $ | (982,748 | ) | $ | 19,440,641 |
|
| administrative expenses | | | | | | |
| Advertising, Cooperative | | | | | | |
| and promotions | | | $ | 7,142,284 |
| $ | (1,917,492 | ) | $ | (1,316,463 | ) | $ | 3,908,329 |
|
| Research and development | | | $ | 769,637 |
| — |
| — |
| $ | 769,637 |
|
| Provision for doubtful | | | | | | |
| accounts | | | $ | (26,851 | ) | — |
| — |
| $ | (26,851 | ) |
| Interest expense | | | $ | 299 |
| — |
| — |
| $ | 299 |
|
| | | | | | | |
| Total Costs and Expenses | | | $ | 52,831,693 |
| $ | (7,679,195 | ) | $ | (5,850,588 | ) | $ | 39,301,910 |
|
| | | | | | | |
| Income (Loss) before Provision for | | | | | |
| (Benefit from) Income Taxes | | | $ | 943,982 |
| $ | 2,974,349 |
| $ | 4,420,058 |
| $ | (6,450,425 | ) |
| | | | | | | |
| Provision for (Benefit from) | | | | | | |
| Income Taxes | | | $ | 478,530 |
| $ | 1,507,778 |
| $ | 2,240,647 |
| $ | (3,269,895 | ) |
| | | | | | | |
| Net Income (Loss) | | | $ | 465,452 |
| $ | 1,466,571 |
| $ | 2,179,411 |
| $ | (3,180,530 | ) |
| | | | | | | |
| Earnings per Share: | | | | | | |
| Basic | | | $ | 0.07 |
| $ | 0.21 |
| $ | 0.31 |
| $ | (0.45 | ) |
| Diluted | | | $ | 0.07 |
| $ | 0.21 |
| $ | 0.31 |
| $ | (0.45 | ) |
| | | | | | | |
Number of Common Shares: | | | | | | |
Weighted average outstanding - Basic | | 7,054,442 | 7,054,442 | 7,054,442 | 7,054,442 |
Weighted average and potential dilutive outstanding | | 7,054,442 | 7,054,442 | 7,054,442 | 7,054,442 |
(7) Represents unaudited revenue and direct expenses for Gel Perfect for the year ended November 30, 2012 |
(8) Represents unaudited revenue and direct expenses for Mega-T for the year ended November 30, 2012 |
|
| | | | | | | | | | | | | | | | |
CCA INDUSTRIES, INC. AND SUBSIDIARIES |
UNAUDITED PRO-FORMA STATEMENT OF OPERATIONS |
FOR THE YEAR ENDED NOVEMBER 30, 2011 |
| | | | | | | | |
| | | | | November 30, 2011 | GP Proforma Adjustment | Mega-T Proforma Adjustments | ProForma |
| | | | | | (9) | (10) | |
Revenues | | | | | | | | |
| Sales of Health and Beauty | | | | $ | 49,033,367 |
| $ | 2,851,184 |
| $ | 13,349,346 |
| $ | 32,832,837 |
|
| aid products-Net | | | | | | | |
| Other Income | | | | $ | 478,522 |
| — |
| — |
| $ | 478,522 |
|
| | | | | | | | |
| | | | | $ | 49,511,889 |
| $ | 2,851,184 |
| $ | 13,349,346 |
| $ | 33,311,359 |
|
| | | | | | | | |
Costs and Expenses | | | | | | | |
| Cost of sales | | | | $ 20,450,468 | $ (1,178,867) | $ (4,563,691) | $ 14,707,910 |
| Selling, general and | | | | $ 21,967,327 | $ (388,844) | $ (1,269,253) | $ 20,309,230 |
| administrative | | | | | | | |
| expenses | | | | | | | |
| Advertising, Cooperative | | | | | | | |
| and promotions | | | | $ 5,436,565 | $ (122,463) | $ (2,542,951) | $ 2,771,150 |
| Research and development | | | | $ 714,565 | — | — | $ 714,565 |
| Provision for doubtful | | | | | | | |
| accounts | | | | $ (11,135) | — | — | $ (11,135) |
| Interest expense | | | | $ 860 | — | — | $ 860 |
| | | | | | | | |
| Total Costs and Expenses | | | | $ 48,558,650 | $ (1,690,174) | $ (8,375,895) | $ 38,492,581 |
| | | | | | | | |
| Income (Loss) before Provision for | | | | | | |
| (Benefit from) Income Taxes | | | | $ | 953,239 |
| $ | 1,161,010 |
| $ | 4,973,450 |
| $ | (5,181,222 | ) |
| | | | | | | | |
| Provision for (Benefit from) | | | | | | | |
| Income Taxes | | | | $ | 461,541 |
| $ | 562,140 |
| $ | 2,408,054 |
| $ | (2,508,653 | ) |
| | | | | | | | |
| Net Income (Loss) | | | | $ | 491,698 |
| $ | 598,870 |
| $ | 2,565,396 |
| $ | (2,672,569 | ) |
| | | | | | | | |
| Earnings (Loss) per Share: | | | | | | | |
| Basic | | | | $ | 0.07 |
| $ | 0.08 |
| $ | 0.36 |
| $ | (0.38 | ) |
| Diluted | | | | $ | 0.07 |
| $ | 0.08 |
| $ | 0.36 |
| $ | (0.38 | ) |
| | | | | | | | |
Number of Common Shares: | | | | | | | |
Weighted average outstanding - Basic | | | | 7,054,442 | 7,054,442 | 7,054,442 | 7,054,442 |
Weighted average and potential dilutive outstanding | | | 7,054,442 | 7,054,442 | 7,054,442 | 7,054,442 |
(9) Represents unaudited revenue and direct expenses for Gel Perfect for the year ended November 30, 2011 | |
(10) Represents unaudited revenue and direct expenses for Mega-T for the year ended November 30, 2011 | |